FIELD: medicine; veterinary.
SUBSTANCE: method of improvement of anesthesia recovery quality by means of decrease of excessive vocalization, senseless movement and ataxia or their combination consists of administration to an animal of therapeutically effective compound of the formula and , where R2 is selected from the group consisting from methyl, ethyl, isopropyl, sec-butyl and tert-butyl. The pharmaceutical composition of the same purpose contains therapeutically effective quantity of the compound of the formula (I) or (1a), sulphobutyl ester β-cyclodextrin, preservative agent - m-cresol, and pharmaceutically acceptable carrier and diluent. The invention refers also to use of the specified compounds in the drug production for improvement of anesthesia recovery quality by means of decrease of excessive vocalisation, senseless movement and ataxia or their combination.
EFFECT: decrease of vocalisation and risk of injury because of senseless movements or ataxia during anesthesia recovery in animals.
8 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIMICROBIAL PRESERVATIVES FOR OBTAINING MULTIDOZE COMPOUNDINGS USING β-CYCLODEXTRINES FOR LIQUID MEDICINAL FORMS | 2005 |
|
RU2332997C2 |
ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
USE OF TRADIPITANT FOR MOTION SICKNESS | 2019 |
|
RU2808669C2 |
METHOD FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES WITH TRADIPITANT | 2018 |
|
RU2797248C2 |
METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2667010C2 |
METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2824132C2 |
BENDAMUSTINE AND CYCLOPOLISACCHARIDE COMPOSITION | 2011 |
|
RU2647368C2 |
PHARMACEUTICAL COMPOSITION AND METHODS FOR USE | 2017 |
|
RU2719450C1 |
COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR, COMPOSITION OF RAS-FARNESYLT RANSFERASE INHIBITOR, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2230062C2 |
ANTAGONISTS NEUROKININ-1 COMPOSITIONS FOR INTRAVENOUS INTRODUCTION | 2010 |
|
RU2642234C2 |
Authors
Dates
2008-11-10—Published
2005-01-06—Filed